ACHE and Alzheimer disease: Galantamine is a newly available cholinergic drug that counteracts AD by specifically and reversibly inhibiting acetylcholinesterase (AChE) and altering the nicotinic cholinergic receptors, thereby reducing central cholinergic neurotransmission (Li et al., 2019).